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Abstract
Vaccinia virus (VACV) uses microtubules for export of virions to the cell surface and this process requires the viral protein
F12. Here we show that F12 has structural similarity to kinesin light chain (KLC), a subunit of the kinesin-1 motor that binds
cargo. F12 and KLC share similar size, pI, hydropathy and cargo-binding tetratricopeptide repeats (TPRs). Moreover,
molecular modeling of F12 TPRs upon the crystal structure of KLC2 TPRs showed a striking conservation of structure. We
also identified multiple TPRs in VACV proteins E2 and A36. Data presented demonstrate that F12 is critical for recruitment of
kinesin-1 to virions and that a conserved tryptophan and aspartic acid (WD) motif, which is conserved in the kinesin-1-
binding sequence (KBS) of the neuronal protein calsyntenin/alcadein and several other cellular kinesin-1 binding proteins, is
essential for kinesin-1 recruitment and virion transport. In contrast, mutation of WD motifs in protein A36 revealed they
were not required for kinesin-1 recruitment or IEV transport. This report of a viral KLC-like protein containing a KBS that is
conserved in several cellular proteins advances our understanding of how VACV recruits the kinesin motor to virions, and
exemplifies how viruses use molecular mimicry of cellular components to their advantage.
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Introduction
Vaccinia virus (VACV) is a large DNA virus that replicates in
the cytoplasm [1] and produces morphologically distinct virions
that have different roles in virus dissemination [2,3]. Virus
replication occurs in cytoplasmic factories and starts with the
formation of membrane crescents, composed of lipid and viral
protein. These extend into spherical or oval immature virions (IVs)
containing the viral genome and core proteins [4,5]. IVs undergo
proteolytic processing of some capsid proteins to form intracellular
mature virus (IMV), which mostly remain intracellular and are
released only following cell lysis. However, some IMV are
transported on microtubules [6,7] to a site of membrane wrapping
where they obtain a double membrane [8–10] derived from early
endosomes and/or the trans-Golgi network, to form the intracel-
lular enveloped virus (IEV) [11–13].
For export of virions to the cell periphery, IEV particles are
transported on microtubules utilising kinesin-1 [14–17] and this
process requires the VACV protein F12 [18–20] and is influenced
by protein A36 [15,17,19], which can bind to KLC in vitro [21].
Metazoan kinesin-1 transports cargo toward the plus-end of
microtubules and is a heterotetramer comprising two kinesin
heavy chains (KHCs) and two kinesin light chains (KLCs). KHC
contains an N-terminal motor domain, a long coiled-coil stalk
interrupted by a central hinge, and a globular tail domain [22].
The KLCs contain N-terminal heptad repeats, which interact with
the central coiled stalk of the KHCs, followed by tetratricopeptide
repeats (TPRs) that bind cargo [23]. Both KHCs and KLCs have
been implicated in attaching kinesin-1 to cargo [24]. KLCs bind
diverse cargos through a 34-amino-acid TPR [25,26] comprising a
repeating pattern of small and large amino acids [27]. Recently,
the structure of the KLC2 TPRs was solved by crystallography
(pdb ID:3CEQ). Cargo proteins binding to the KLC-TPR motif
include the MAP kinase scaffolding proteins called JIPs (Jun-N-
terminal kinase interacting proteins) [28], Kidins220/ARMS [29],
calsyntenin/alcadein [30], collapsin response mediator protein-2
(CRMP-2 [31]), Huntington-associated protein-1 [32], torsinA
[33], 14-3-3 [34], the amyloid precursor protein of axonal vesicles
[35], Cayman ataxia protein caytaxin [36], VACV A36 [17,21]
and the Salmonella protein PipB2 [37]. The C-terminal region of
KLC also influences cargo binding [38]. Mechanisms for cargo
binding to, and release from, the KLC TPR are important aspects
of cell biology [39–41].
When an IEV particle reaches the cell periphery, it dissociates
from kinesin-1 and this process is influenced by phosphorylation of
A36 [42] and by VACV protein A33 which binds to the same
region of A36 that binds kinesin-1 [21]. IEV then traverses the
actin cortex [43] and fuses its outer membrane with the plasma
membrane to expose a virus on the cell surface called cell
associated enveloped virus (CEV) [2]. A36 is then phosphorylated
by tyrosine kinases [44,45] and this causes recruitment of cell
proteins Nck, Grb2, N-WASP and Arp2/3 and polymerisation of
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actin beneath the CEV particle [42,44,46–49]. If CEVs are
released from the cell they are called extracellular enveloped
viruses (EEVs). CEVs are important for cell-to-cell spread,
whereas EEVs mediate long-range dissemination of virus. Defects
in either microtubule-based transport of IEV or actin tail
formation beneath CEV, cause a small plaque phenotype and
severe attenuation [2,3].
This paper concerns the transport of IEV to the cell surface and
the roles of F12 and A36 proteins in that process. F12 and A36 are
each important for virus transport within or between cells and
have been called transport proteins [2]. However, these proteins
have different roles. A36 is a membrane protein that is expressed
early and late during infection and is important for plaque size and
virulence [50]. It has type Ib membrane topology, is localised to
the IEV outer membrane [18] and is required for actin tail
formation [44,51,52]. A36 can bind KLC in vitro via aa residues
81–111 [15]. However, A36 is not needed for IEV transport or
CEV formation. A deletion mutant lacking gene A36R, vDA36R,
produced numerous CEV visible by electron microscopy
[14,51,52] and confocal microscopy [18,19]. Furthermore, live
video microscopy of EGFP-tagged virions lacking A36 showed that
A36 negative IEV are transported to the cell surface at 60% of
wild type levels by 24 h p.i. [19]. These IEV moved at speeds
characteristic of microtubule-based transport and this movement
was inhibited reversibly by microtubule de-polymerising drugs
[19]. These observations indicate that VACV must have at least
one other protein to bind kinesin-1 for microtubule-based
transport. In contrast to these reports, another study concluded
A36 was essential for IEV transport [17].
F12 is a 65-kDa protein that lacks transmembrane sequences
and is conserved in chordopoxviruses [20]. Disruption of its
orthologue in fowlpox virus by insertional mutagenesis caused a
small plaque phenotype and a reduction in EEV [53]. A VACV
deletion mutant lacking F12L, vDF12L, also produced a small
plaque, did not form actin tails and was highly attenuated in vivo
[20]. Subsequent analysis showed that F12 was associated with
IEV particles and was needed for IEV transport but not IEV
formation [18,19]. Recently, F12 was reported to form a complex
with VACV protein E2, without which CEV and EEV levels were
reduced by 2 logs and the virus formed a small plaque [54,55]. F12
also interacts with A36 and this interaction was proposed to recruit
F12 to IEV [56]. Collectively, these observations show that IEV
transport to the cell surface has a greater dependency on F12 than
A36.
Here we show that F12 has structural similarity to KLC and
contains TPRs and a WD motif that is required for kinesin-1
recruitment and virion transport. In contrast, WD motifs in A36
were not required for either process. Furthermore, TPRs were
identified in proteins A36 and E2. We propose that F12 functions
as a bridge to bind IEVs to the kinesin-1 motor. F12 interaction
with IEV may be mediated by TPR:TPR contacts between F12,
E2/A36, and kinesin-1 binding is mediated by the WD motif
found in F12 and cellular kinesin-1 binding proteins.
Results
F12 exhibits sequence similarity to KLC cargo-binding
tetratricopeptide repeats
The F12 protein from VACV strain WR F12 (WRF12) is
conserved in other VACV strains, orthopoxviruses and chordo-
poxviruses [20] implying an important function. Previous BLAST
analysis failed to reveal sequence similarity between F12 and host
proteins [20,55,56], but further analysis here identified a pattern of
conserved aromatic residues (phenylalanine, tyrosine and trypto-
phan – Figure 1 red asterisks) and small hydrophobic residues
(leucine, proline and valine) similar to the cargo-binding TPRs of
KLC (Figure 1, between vertical bars). Indeed, the entire F12
protein could be aligned with human KLC1 and KLC2 (Figure 1).
HsKLC1 and HsKLC2 share 61% aa identity (71% aa similarity),
but have only 12% aa identity (50% aa similarity) with VACV
F12. Nonetheless, these proteins have similar size and charge
(HsKLC1, pI 5.94, Mr 64.7 kDa; HsKLC2, pI 6.72 Mr 68.9 kDa;
WR F12, pI 5.76, Mr 73.2 kDa), and similar oscillating
hydropathy profiles without transmembrane regions (Figure S1).
Like KLC, F12 is a cytosolic protein as shown by Triton X-114
partitioning (Figure S2) in agreement with a recent report [56],
however, F12 lacks the heptad repeats near the N terminus of
KLC for binding KHC.
The TPR (NCBI CDD cd00189) is a common structural motif
facilitating protein-protein interactions and the assembly of multi-
protein complexes. The repeat comprises a pattern of small and
large amino acids [WLF]-X(2)-[LIM]-[GAS]-X(2)-[YLF]-X(8)-
[ASE]-X(3)-[FYL]-X(2)-[ASL]-X(4)-[PKE] with no position in-
variant [27]. Structurally, TPRs form paired helices of two types:
an A/B interaction within each helical pair is mediated by
conserved small amino acids that zipper the first two helices
together; and a B/A9 interaction that links one helix pair to the
next, mediated by conserved aromatic residues. TPRs are
evolutionarily conserved and a cluster of three consecutive TPRs
is the most common organization [27]. Alignment of VACV F12
and related proteins from other chordopoxviruses ([20] and Figure
S3) shows a pattern of bulky and intervening small hydrophobic
residues that resemble TPRs and are conserved between these
proteins. F12 has 14 TPR-like sequences constituting 80% of the
protein (Figure S3).
F12 interacts with VACV proteins A36 [56] and E2 [55], and
A36 can also interact in vitro with KLC TPRs via aa 81–111 [21].
Since TPRs mediate protein interactions [27], we wondered if A36
or E2 also contained TPRs. Surprisingly, examination of these
proteins identified three TPR-like sequences in A36 and fifteen
TPRs in E2 (72% of E2) (Figure 2). These observations suggested
the association of A36 and E2 with F12 might be via TPR:TPR
interactions, and TPR:TPR interactions might also facilitate A36
interaction with KLC. Consistent with the former hypothesis, F12
and A36 interact via residues 351–458 of F12, and 91–111 of A36,
which overlap the TPRs [56].
Based on the x-ray crystallographic structure of the KLC2 6
TPRs (pdb ID:3CEQ), and its alignment with the F12 protein
(Figure 1), a structural model of F12 TPRs 7–12 was built using
the program MODELLER (Figure 3). This model satisfied all
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Vaccinia virus (VACV), the vaccine used to eradicate
smallpox, exploits the host cell motor kinesin-1 to export
virus particles to the cell surface. We demonstrate that the
VACV F12 protein has structural similarity with kinesin light
chain (KLC) and facilitates viral transport using a kinesin
binding sequence (KBS) that is conserved in several
neuronal proteins. Dysfunction of some of these neuronal
proteins can contribute to diseases, such as Alzheimer’s.
Mutation of the KBS in protein F12 showed it is essential
for kinesin recruitment to virions and for virion transport to
the cell surface. These findings enhance our understanding
of how viruses hijack the host cell transport system,
demonstrate conservation of a kinesin binding motif in
cellular and viral proteins and identify targets for drug
development.
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geometric and stereochemical constraints and the overall fold of
the F12 TPRs 7–12 was remarkably similar to that of KLC2 TPRs
(Figure 3A, B). Superimposition of KLC2 and F12 showed a very
close match with variation restricted to loops connecting adjacent
TPRs (Figure 3C). Importantly, the key hydrophobic residues that
mediate hydrophobic interactions between the 2 alpha helices of
the TPR fold, which are the hallmark of TPR domains, are
structurally conserved between F12 and KLC2 (Figure 3D).
Similar results were found for the F12 TPRs 1–6 (data not shown).
Overall, analysis of the F12 primary sequence and predicted
tertiary structure provides strong evidence of a TPR-containing
protein with structural similarity to KLC.
The entire F12 protein is required for IEV motility
In previous studies, deletion of the F12L gene showed the
protein is not required for IEV formation but is needed for IEV
transport to the cell periphery and CEV formation [18,19]. To
investigate which domains of F12 are needed for function, we
generated a panel of N- and C-terminal truncations of F12-HA
(Figure 4A) and cloned these into the pSEL vector downstream of
a VACV promoter [57]. These F12L alleles were transfected into
cells infected with vDF12L and rescue of IEV transport to the cell
surface was measured by first staining live cells with anti-B5 mAb
for counting CEV, and second by staining permeabilised cells with
phalloidin and counting virus-tipped actin tails [58]. Immuno-
blotting lysates of HeLa cells infected with the deletion F12 virus
and transfected with the F12-HA mutant alleles confirmed the
mutants expressed stable proteins of the expected size (Figure 4B).
In cells infected with vDF12L, IEV particles were located in the
centre of the cell, and CEV and actin tails were not present
[18,19]. In contrast, when full length F12-HA was expressed in
these cells, it localised to structures in the cytosol and cell
periphery typical of IEV (Figure 4C, cyan) and there were
numerous B5 positive CEV (Figure 4C, red) and actin tails
(Figure 4C, green; D). In comparison, all the F12 mutants failed to
induce IEV dispersal to the cell periphery and did not generate
CEV or actin tails (Figures 4C, D, S4). Importantly, the failure of
vDF12L IEV to move to the cell surface was not due to the lack of
Figure 1. F12 has similarity to KLC. VACV strain WR F12 (WRF12) was aligned with human KLCs 1 and 2 (HsKCL1, HsKCL2). Identical residues are
boxed and conserved residues are shaded. Vertical bars and arrows indicate the positions of HsKLC TPRs. The red asterisk above the alignment
denotes the conserved aromatic residues in TPRs. The F12 WD motif at aa residues 534 to 538 is underlined and residues 351–458 (blue) have been
shown to bind A36 [56]. Accession numbers are WR F12 (AAO89330), HsKLC1 (AA01263), and HsKLC2 (Q9H0B6).
doi:10.1371/journal.ppat.1000785.g001
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recruitment of A36 to virions, because confocal microscopy of
vDF12 IEV particles tagged with EGFP (vDF12L-EGFPA5L)
[19,59] (Figure 4E) and cryoimmunoelectron microscopy (Figure 5)
showed A36 was present on vDF12L IEV. Moreover, A36 is non-
essential for IEV transport as vDA36R IEV are transported on
microtubules [19].
F12 is required for kinesin-1 recruitment
The important role of F12 in IEV movement suggests the
protein may function in kinesin recruitment and/or activation
[19]. To investigate this, the localisation of F12-HA and kinesin-1
was determined in vF12LHA-infected cells. Cells were processed
for immunofluorescent microscopy after staining with a rat mAb
against the HA tag [18] and with antiserum against KHC [60]
(Figure S5). In mock-infected HeLa cells no specific anti-HA signal
was detected and KHC was localised to structures in the cytoplasm
as reported [60] (Figure S5, top row of panels). However, in
infected cells KHC was predominantly located at the cell
periphery and in punctate structures throughout the cell (Figure
S5, bottom row, green), and a similar distribution was observed for
F12-HA (Figure S5, bottom row, red). The merged image (Figure
S5, bottom row, merge) showed a high degree of co-localisation,
indicating kinesin-1 is recruited to F12-HA positive IEV particles
in the cell periphery. The coincidence of F12-HA and kinesin-1 on
IEV are consistent with F12 contributing to recruitment and
retention of kinesin-1 allowing efficient transport.
The requirement of F12 for IEV motility is consistent with the
suggested role in kinesin-1 recruitment and/or function. This was
investigated further by confocal microscopy using viruses that have
EGFP fused to the A5 core protein, and do or do not express F12,
vEGFPA5L [61] and vDF12L-EGFPA5L [19]. In cells infected
with vEGFPA5L, kinesin-1 co-localised with virions in the cell
periphery, with similar results observed for the KHC and KLC
(Figures 6 and 7). In contrast, after infection with vDF12L-
EGFPA5L, kinesin-1 was not recruited to IEV and remained
diffuse in the cytoplasm (Figures 6 and 7). Cryoimmunoelectron
microscopy confirmed KLC was recruited to wild type WR IEV
and showed it was absent from vDF12L IEV (Figure 5). The
recruitment of kinesin-1 to wild type IEV but not vDF12L IEV
despite the presence of A36 in both cases, demonstrates F12 is
needed for kinesin recruitment and A36 alone is not sufficient.
F12 and E2 are not required for IEV formation
In the first paper describing E2 and its role in the VACV life
cycle Domi et al [54] reported that without E2 there was a 100-
fold reduction in extracellular virus. Electron microscopy and
Figure 2. Alignment of TPRs of VACV proteins F12, A36, and E2 with KLC TPRs. The TPRs of A36, E2 and F12 were aligned using Clustal-X
and are displayed using the Clustal colour scheme (http://www.jalview.org/help/html/colourSchemes/clustal.html). The amino acid co-ordinates of
each TRP domain are listed on the right. The TPR consensus sequence is shown above. Accession numbers are WR F12 (AAO89330), WR E2
(YP_232940) and WR A36 (YP_233041).
doi:10.1371/journal.ppat.1000785.g002
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Figure 3. Structural model of F12 TPRs. The three-dimensional structure of the KLC2 TPRs (A) compares favourably with the model of the F12
TPR domains 7–12 (B) illustrated by an overlay of the two structures (C). (D) KLC2 TPR 1 is overlaid with F12 TPR 6 illustrating the spatial conservation
of key hydrophobic aa side-chains responsible for holding together the two alpha helices that comprise a single TPR domain.
doi:10.1371/journal.ppat.1000785.g003
Vaccinia F12 Structural Mimicry of Kinesin
PLoS Pathogens | www.plospathogens.org 5 February 2010 | Volume 6 | Issue 2 | e1000785
analysis of several hundred virions in infected cells, showed there
were comparable numbers of immature virions, IMVs and IEVs
but the amount of CEV/EEV was reduced dramatically [54]. In a
later paper Dodding et al [55] examined morphogenesis of vDE2L
and vDF12L using electron microscopy of thick sections of infected
cells and concluded that there was a defect in wrapping of IMVs to
form IEVs in both cases [55]. In the light of these conflicting
reports, we used thin section transmission electron microscopy, tilt
series analysis and serial section analysis to re-investigate the roles
of F12 and E2 in IEV morphogenesis. Thin section analysis of
HeLa cells infected with WR, vDE2L and vDF12L showed the
usual stages of IEV morphogenesis for all viruses, namely IMV
association with wrapping membrane (Figure 8A–C), IEV
(Figure 8D-F, K and L), and IEV with loose wrapping membrane
(Figure 8G–I). With wild type (WR) virus there were numerous
CEV/EEV particles outside the cell (Figure 8J), but these were not
seen with either vDE2L or vDF12L. To determine if the
proportions of the different virions varied between wild type and
mutants, viral particles were counted in thin sections and the
percentage of IMV, partially wrapped IEV, completely wrapped
IEV and CEV was determined (Figure 9). Loss of F12 and E2
cause no difference in the number of IMV, or partially wrapped
IEV relative to wild type, but there was a three-fold increase in
IEV with vDE2L and vDF12L. The increase in IEV is likely
attributable to inefficient transport of vDF12L and vDE2L IEV to
the plasma membrane, consistent with the lack of CEV formed by
these viruses. Notably the sum of IEV and CEV for each mutant
was equivalent to wild type.
By counting many virus particles (n=100) for each virus in our
study, it was unlikely that any defect in IEV wrapping would have
been missed in the thin sections examined. Similarly, Domi et al
[54] examined several hundred vDE2L virions and found
numerous normal IEV. However, to further investigate IEV
wrapping we analysed serial sections of vDF12L (Figure 10, A, E,
I, M) and vDE2L IEV (Figure 10, C, G, K, O). In addition, we
undertook tilt series analysis to bring membranes perpendicular to
the electron beam, and therefore in sharp focus, for vDF12L
(Figure 10, B, F, J, N) and vDE2L IEV (Figure 10, D, H, L, P). For
Figure 4. Full length F12 is required for IEV transport. (A) Illustration of HA-tagged F12 mutant proteins analysed. (B) HeLa cells were infected
with vDF12L at 5 pfu/cell and were transfected with plasmids encoding F12-HA at 2 h post infection. After 10 h cells were lysed and lysates were
immunoblotted with anti-HA mAb. The blot was stripped and reprobed with anti-D8 mAb (a VACV protein) to confirm the equivalence of loading. (C,
D) Rescue assay demonstrating that the full length F12-HA protein is required for the formation of cell surface virions and actin tails. HeLa cells were
infected with vDF12L-EGFPA5L at 5 pfu/cell for 2 h and then were transfected with plasmids expressing F12 for 10 h. Cells were stained with anti-B5
mAb (red) prior to fixation and staining with anti-HA mAb (cyan) and phalloidin (green). Inset shows B5-positive virus-tipped actin tails. Loss of
surface B5 labelling and actin tail formation in cells transfected with the F12-HA truncations demonstrated virions have not reached the cell surface.
Actin tails were counted and data were expressed as the percentage of actin tails formed by each mutant compared to WT. Data are from a single
experiment that is representative of three. (E) A36 is localised to vDF12L IEV. Cells infected as in (C) were permeabilised and stained for A36 (red) or
visualized for EGFP. The merged image shows A36-positive IEV particles (arrows). Scale bars C = 10 mm, E = 5 mm.
doi:10.1371/journal.ppat.1000785.g004
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both viruses this demonstrated the presence of many completely
wrapped IEV with double membranes surrounding IMV
(Figure 10). Moreover, in cases where membranes were not in
sharp focus in one plane, that might suggest incomplete wrapping,
tilting the section 650u brought these double membranes into
sharp focus as they became perpendicular to the electron beam,
see full tilt series animation of vDF12L in Video S1. We conclude
that vDE2L and vDF12L form IEV normally and are indistin-
guishable from wild type. The lack of vDF12L IEV transport to the
plasma membrane is therefore not due to a morphological defect
but to failure to recruit kinesin-1.
Kinesin-1 is recruited via a kinesin binding sequence (WD
motif) in F12
Data presented show that F12 is required for kinesin-1
recruitment and IEV transport. To investigate further how F12
might recruit kinesin-1 we searched for known kinesin-1 binding
sequences (KBS) within the F12 protein. A recent study identified
Figure 5. Cryoimmunoelectron microscopy showing F12 is needed for KLC, but not A36, recruitment to IEV. Cryoimmunoelectron
microscopy of ultrathin sections of HeLa cells infected with VACV WR (top) or vDF12L (bottom) and stained for B5, A36 or KLC with mAbs followed by
6-nm gold particles. Note B5 and A36 are present on VACV WR and vDF12L IEV, but KLC is recruited to VACV WR IEV (arrows) but not to vDF12L IEV.
Scale bar = 100 nm.
doi:10.1371/journal.ppat.1000785.g005
Figure 6. F12 is required for KHC recruitment. HeLa cells were infected with vEGFPA5L (top) or vDF12-EGFPA5L (bottom) at 5 pfu/cell for 12 h.
Cells were then fixed, permeabilised and stained for KHC (red) and visualized for EGFP (green). The merged image shows KHC recruitment to IEV
particles at the periphery of the cell in vEGFPA5L-infected cells. Note KHC recruitment to IEV particles does not occur in cells infected vDF12-EGFPA5L.
Scale bar = 10 mm.
doi:10.1371/journal.ppat.1000785.g006
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two copies of a KBS in the neuronal transmembrane protein
calsyntenin/alcadein conforming to the consensus sequence L/M–
E/D–W–D–D–S, termed the WD motif, after the conserved
tryptophan and aspartic acid residues [30,62]. A WD motif is also
present in the Cayman ataxia protein caytaxin, which also binds
KLC [36]. The calsyntenin study also identified a putative KBS
within protein A36 (L–I–W–D–N–E, residues 95 to 100) [30].
Inspection of the WR F12 protein revealed a similar motif L–Q–
W–D–D–N at residues 534 to 539 (underlined in Figure 1) and
further analysis showed this WD motif is conserved in F12
orthologues from chordopoxviruses of diverse genera with the
consensus sequence L-E-W-E-E/D-S (Figure 11A). In VACV
strains Ankara, Lister and Copenhagen this sequence is L–Q–W–
D–N–N and the D to N substitution makes the sequence more
similar to the WD motif in A36.
A search for the WD motif in other cellular proteins identified
similar sequences in the collapsin response mediator protein-2, 14-3-
3 protein and amyloid precursor protein with the consensus
sequence (L-E/D-W-D-D-S) (Figure 11B). These proteins are
known to bind KLC TPRs. Overall this analysis suggests the WD
kinesin-1 binding motif conforms to the sequence L-E/D-W/Q-D/
E-D/E-S/N (where Q is an aromatic residue other than tryptophan).
The roles of the F12 WD motif in kinesin-1 recruitment and
IEV transport were investigated by mutation of WDD to AAA, a
mutation that abrogates kinesin-1 binding by calsyntenin/alcadein
[30]. Confocal microscopy demonstrated that wild-type F12-HA
and KHC were targeted to EGFP positive IEV in the cell
periphery (Figure 12A) and that actin tails were formed from the
surface of these cells (Figures 12B & 13). In contrast, mutation of
the WD motif blocked the recruitment of F12-HA and KHC to
IEVs (Figure 12A), and most virions remain centrally localised
with very few particles moving to the cellular periphery or
generating actin tails (Figure 12B). This loss of F12 function was
not due to instability of the F12 mutant protein because
immunoblotting showed that F12-HA WT and F12-HA AAA
were present at similar levels (Figure S6). Mutation of the F12 WD
motif reduced cell surface actin tails by 98% (Figure 12B and 13),
demonstrating that the WD motif is necessary for IEV recruitment
and transport. However, it is not sufficient because F12 mutants
retaining the WD motif, but lacking other parts of the protein do
not enable virion motility (Figure 4D, S4).
In parallel we also investigated the role of the WDmotif (L–I–W–
D–N–E) within protein A36 reported in the calsyntenin study [30].
Bioinformatic analysis found the sequence is conserved in A36
orthologues from chordopoxviruses and an alignment of these
sequences is shown in Figure S7. Similar mutational analysis of the
A36-HA protein showed the A36-AAA-HA protein is stable (Figure
S6), recruited to IEV (Figure S8A) and enables IEV transport to the
cell surface where actin tails were formed at 69% of wild-type level
(Figure 13, S8B). This small defect in IEV transport/actin tail
formation is comparable to that observed following deletion of the
entire A36R gene, where IEV still move on microtubules and reach
the cell surface at 60% of wild type levels [19].
We also identified another putative KBS in VACV A36 (S-D-
W-E-D-H, residues 62–67) that only conforms partially to the WD
consensus sequence. Although this motif is not conserved outside
of the orthopoxvirus A36 orthologues, we undertook a similar
mutagenic analysis. Mutation of the WED to AAA alone, or in
addition to the WDN to AAA at residues 97–99 to form a double
mutant, gave no phenotype (data not shown). This mutagenic
analysis demonstrates the WD motif present within F12, but not
those in A36, is critical for microtubule-mediated virion transport.
Figure 7. F12 is required for KLC recruitment. HeLa cells were either mock-infected or infected at 5 pfu/cell with vEGFPA5L or vDF12-EGFPA5L.
At 12 h p.i. cells were fixed, permeabilised and stained for KLC (red), DAPI (blue) or visualized for EGFP (green). The merged image is shown on the
right. Note KLC is recruited to IEV particles at the periphery of the cell in vEGFPA5L-infected cells, but not in cells infected with vDF12-EGFPA5L. Scale
bar = 10 mm.
doi:10.1371/journal.ppat.1000785.g007
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Figure 8. F12 is not required for IEV formation. HeLa cells were infected at 5 pfu/cell with WR (A, D, G, J), vDF12L (DF12) (B, E, H, K) or vVAC-
BACDE2L (DE2) (C, F, I, L) for 12 h. Cells were then processed for thin 70-nm serial-section analysis using conventional electron microscopy. Images
show virions at different stages of morphogenesis: (A–C) IMV association with wrapping membranes, (D–F, K and L) complete IEV, (G–I) complete IEV
in which part of the wrapping membrane is not tightly associated with the virions, and (J) CEV/EEV formed by WR. Micrographs A–J & L are shown at
the same magnification. Scale bars = 200 nM.
doi:10.1371/journal.ppat.1000785.g008
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Discussion
How motor proteins select and bind intracellular cargo is an
important biological question. The importance of intracellular
transport is highlighted by the fact that mutations in motors lead to
genetic diseases such as amyotrophic lateral sclerosis, paraplegia
and Griscelli syndrome type 1 [63]. Kinesin-1, the archetypal
member of the kinesin superfamily, drives the transport of diverse
cellular cargos such as neuronal vesicles, secretory vesicles,
endocytic structures, mitochondria and mRNP particles and has
been implicated in the dynamics of the endoplasmic reticulum
(ER) and Golgi apparatus [64]. Kinesin-1 is involved in the
intracellular motility of pathogens and in the development of
neurodegenerative disorders including Alzheimer’s disease. Hence,
studying factors coordinating kinesin-1 cargo binding is of
biological and clinical importance.
This paper concerns how VACV exploits kinesin-1 for transport
of virions to the cell periphery. We have discovered that VACV
transport protein F12 is structurally related to KLC and shares
with KLC a similar size, pI, hydrophobicity profile and TPRs.
Bioinformatic analysis and structural modelling of F12 TPRs 7–12
with the recently described crystal structure of KLC2 TPRs
showed a striking structural similarity. A close relationship was also
found for F12 TPRs 1–6, suggesting that F12 might have evolved
by duplication of the TPR domain of KLC accompanied by
deletion of the N-terminal heptad repeats. Mutagenesis of the F12
protein showed that deletion of these TPRs from either terminus
abrogated F12 function, implying an important role for TPRs.
Although these mutant proteins were reasonably stable in virus-
infected cells, we cannot exclude the possibility that the loss of
function was due to aberrant folding of truncated proteins. F12
also contains a WD kinesin-1 binding motif that is found in several
cellular cargo proteins and mutagenesis demonstrated that the F12
WD motif is critical for recruitment of kinesin-1 and IEV
transport. A model consonant with these observations is that
F12 binds cargo (virions) via TPR:TPR interactions with E2 (or
A36, although A36 is not essential for IEV binding to microtubules
and transport), and that it uses the WD motif to attach to KLC
and thereby the kinesin-1 motor. Thus F12 functions as a bridge
between microtubule motor and virus particle. Recently, the
Cayman ataxia protein caytaxin was proposed to have an
analogous function and shown to bind to KLC TPRs via a WD
motif and mediate transport of cargos, such as mitochondria, by
specific binding to these structures [36].
This example of VACV mimicry of a host cell protein adds to a
growing list. Other examples include K3, a mimic of eukaryotic
initiation factor 2a [65], A44, a 3b-hydroxysteroid dehydrogenase
[66], B15, a soluble interleukin-1b receptor [67] and proteins N1,
B14 and A52 that have Bcl-2 structures and inhibit apoptosis or
NF-kB signaling [68–70]. However, the F12 protein represents the
first example of a VACV protein mimicking a host cell motor
protein and to our knowledge is the only viral KLC structural
mimic described.
TPRs in F12 and other VACV IEV proteins
In addition to finding TPRs in F12, we report that TPRs are
also present in proteins E2 and A36 which, like F12, have a role in
IEV formation or transport. TPRs mediate protein-protein
interactions and therefore the presence of TPRs in several VACV
proteins that associate with each other suggests that these
interactions might be via TPR:TPR contacts. Consistent with
this, F12 and A36 interact through residues 351–458 of F12, and
91–111 of A36, which overlap the TPRs of both proteins [56].
The region of A36 needed to bind to KLC in vitro (aa 81–111) [21]
also overlaps the A36 TPRs reported here. A recently described
function of the KLC TPRs is in the activation of the KHC upon
cargo binding [71] and it is possible that F12 may have a similar
effect.
Regulation of kinesin-1 recruitment to IEV
Previously, immunoelectron microscopy demonstrated that F12
is associated transiently with VACV during morphogenesis and
egress and is present only on IEV, but not IV, IMV or CEV [18].
Confocal microscopy also showed that F12 co-localised with IEV
particles but was absent from CEV particles associated with actin
tails at the cell surface [18,55]. Furthermore, although IEV were
formed in the absence of F12, they were not transported to the cell
periphery and consequently morphogenesis was arrested prior to
the formation of CEV and actin tails [18,19]. Recently, Dodding
et al [55] challenged the view that IEV are formed without F12 or
E2. Using thick sections of infected cells they concluded that only
incompletely wrapped IEV were formed, but we wondered if the
resolution of the images presented was sufficient to allow such a
conclusion. Previously, high resolution images of thin sections of
vDF12L-infected cells showed multiple IEVs with continuous
outer membranes [18]. Similar images are presented here and
these were indistinguishable from wild type. In addition, we
undertook serial section and tilt series analyses that showed both
F12 and E2 deletion viruses wrap normally. Therefore, the
transport defect observed in these mutants is not caused by a
failure to form IEV. These observations are consistent with a role
for F12 in IEV transport on microtubules to the cell periphery. To
investigate this, we showed here that F12 and kinesin-1 are both
present on IEV particles and, in the absence of F12, kinesin-1 was
not recruited to IEV. Notably, immunoelectron microscopy and
confocal microscopy demonstrated that A36 was still recruited to
IEV in the absence of F12, showing A36 is not sufficient for
kinesin-1 recruitment.
Figure 9. Enumeration of types of virion produced by WR,
vDF12L and vDE2L. HeLa cells were infected at 5 pfu/cell with WR,
vDF12L or vVAC-BACDE2L for 12 h. Cells were then fixed and processed
for conventional electron microscopy. Viral particles (n= 100) were
counted in thin sections and the percentage of IMV, partially wrapped
IEV, completely wrapped IEV and CEV were determined and are
expressed as a percentage of total virions. Note: i) loss of F12 and E2
caused no difference in the number of partially wrapped IEV relative to
wild type but there were three times as many IEV in cells infected with
deletion viruses; ii) No CEV were seen for the deletion mutants but the
sum of IEV/CEV were equivalent for mutants compared to wild type.
doi:10.1371/journal.ppat.1000785.g009
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To investigate which domains of F12 are needed for kinesin-1
recruitment and IEV transport, we utilised a rescue assay in which
cells are infected with a mutant virus lacking the F12L gene and
then are transfected with wild type F12 tagged with HA (F12-HA),
or with mutants thereof. F12 function was assessed by kinesin-1
recruitment, dispersal of virions to the cell periphery, CEV
formation and the production of actin tails from the cell surface.
This showed that all F12 mutants tested with deletions from either
terminus were non-functional, and mutation of the WDD motif to
AAA also inhibited both kinesin-1 recruitment and IEV transport.
A direct F12:kinesin-1 interaction was not detected in previous
yeast two hybrid screens [21]. However, this does not preclude a
direct interaction because F12 may act with additional factors on
the IEV surface to recruit kinesin-1. Also, the interaction between
A36 and KLC seen in vitro has still to be demonstrated within
infected cells.
An earlier study describing the WD kinesin-1 binding
sequence in the neuronal transmembrane protein calsyntenin/
alcadein reported that two WD motifs were needed for function,
and these authors reported a WD motif in A36 [30]. In contrast
to the situation with F12, we show here that mutation of the A36
WD motif did not inhibit kinesin-1 recruitment, IEV transport,
Figure 10. Serial section and tilt series electron microscopy showing vDF12L and vDE2L IEV are fully wrapped. Cells were infected and
processed for thin 90-nm serial section electron microscopy as described in Figure 8. Serial section analysis of vDF12L (DF12, A, E, I, M) and or vVAC-
BACDE2L (DE2, C, G, K, O). Tilt series analysis of vDF12L (B, F, J, N) (derived from a different IEV) or vD vVAC-BACDE2L (D, H, L, P) IEV tilted the
indicated degree in the electron beam. For vVAC-BACDE2L, the section shown in (G) was tilted through 20u increments. Note the continuity of the
double membrane forming the IEV particles. All micrographs are shown at the same magnification. Bar, 200 nm.
doi:10.1371/journal.ppat.1000785.g010
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and CEV and actin tail formation. However, it was clear that
these processes were slightly less efficient with the A36 WDN to
AAA mutation, and actin tails were produced at about two thirds
the level of wild type. So the WD motif in F12 and A36 each
play a role, but the requirement for the F12 WD motif is much
more profound and the A36 plays a minor supporting role
(Figure 13). These observations are similar to those resulting
from deletion of the entire A36 protein, which caused a decrease
in the efficiency of IEV transport and CEV formation (60% of
wild type levels at 24 h p.i.) [19]. The results from mutation of
the WD motifs in A36 and F12 have similarity with calsynentin/
alcadein where mutation of either WD motif reduced binding to
KLC1 to 30% compared with wild type calsyntenin/alcadein,
and when both motifs were mutated only 3% of the WT binding
was achieved [30]. This indicates that only one calsyntenin/
alcadein KBS is insufficient to mediate efficient interaction and
that both binding sites are needed for optimal binding to KLC.
The bipartite nature of the WD signal in calsyntenin/alcadein
may explain why two VACV proteins have this motif and both
are needed for optimal efficiency. The more profound require-
ment for F12 may be a mechanism used by VACV to ensure
kinesin-1 is recruited efficiently to only fully formed IEV
containing both F12 and A36, and not just A36 containing
membranes that are used to enwrap IMVs to form IEVs. This
may provide a quality control checkpoint enhancing transport of
fully formed IEV rather than precursors to the cell surface. In
this paper we also identify WD motifs in other proteins that bind
directly to the KLC raising the possibility that the use of co-
receptors may be a common mechanism for kinesin-1 attach-
ment and regulation of cargo transport. Indeed, co-operative
mechanisms of cargo binding to the KLC TPR are currently
being studied [39].
Previously, protein A36 was described as essential for kinesin-1
recruitment to IEV and for IEV transport [17]. However, while it is
evident that A36 does influence IEV transport, several lines of
evidence show it is not critical for this. First, live video microscopy
showed that IEV lacking A36 move at speeds consistent with
kinesin-1 transport, this movement was inhibited by microtubule
depolymerising drugs, and A36 null virions are dispersed to the cell
periphery [19]. Second, several reports using confocal or electron
microscopy have shown CEV are formed in the absence of A36
[14,18,19,51,52]. Third, it is shown here that in the presence of
A36, but absence of F12, kinesin-1 is not recruited to IEV,
indicating A36 is not sufficient for kinesin-1 recruitment. As
mentioned above, this may have an important consequence in
preventing kinesin-1 recruitment to A36 containing membranes
such as the ER, through which it trafficks after co-translational
insertion [72], or the plasmamembrane where it is deposited during
virus egress from the cell [72]. Only fully formed IEV that contain
F12 require kinesin-1 recruitment and transport. It is possible that
Rietdorf et al [17] concluded that A36 is essential for kinesin
recruitment and IEV movement because their investigation was
conducted only early during infection. Herrero-Martinez et al [19]
showed that the transport of vDA36R IEV is delayed compared to
wild type, but by 24 h p.i. the level of CEV reach 60% of wild type.
We conclude that, although A36 plays a minor role, F12 is the more
important protein for kinesin-1 based transport of IEV.
In summary, VACV F12 is a KLC structural mimic containing
TPRs and a KBS, and VACV proteins A36 and E2 also contain
TPRs that may mediate protein:protein interactions. In addition,
we show that the calsyntenin/alcadein WD motif for binding
kinesin-1 is conserved in several other cellular kinesin-binding
proteins and in VACV proteins F12 and A36. The F12 WD motif
is critical for kinesin-1 recruitment and virion transport to the cell
surface, whereas the A36 WD motif plays a supporting role. This
report advances our understanding of VACV transport to the cell
surface and illustrates how poxviruses use molecular mimicry for
subversion of host cell biology.
Materials and Methods
Cells and viruses
HeLa cells were grown in minimum essential medium (MEM)
supplemented with 10% heat-inactivated foetal bovine serum
(Gibco). The viruses used in this study were vaccinia virus (VACV)
strainWestern Reserve (WR) and derivative strains vDF12L, F12-HA
[20], vDA36R [50], vEGFPA5L [61], vDF12L-EGFPA5L and
vDA36R-EGFPA5L [19]. Cells were infected at 5 plaque forming
units (PFU)/cell. For confocal microscopy cells were fixed at 12 h p.i.
DNA manipulation
PCR was performed with Pfu polymerase (Stratagene). The
fidelity of the cloned fragments was verified by DNA sequencing.
Mutants of F12 with N- or C-terminal truncations were
constructed by PCR using VACV WR or vF12L-HA genomic
DNA as template for the C- or N- terminal mutants, respectively.
For the N-terminal mutants, the oligonucleotides 59-GAACA-
AGCTTGCCATCATGGGTATCGAGAATACAGATTCCAT-
39 (F12-DN123); 59- GAACAAGCTTGCCATCATGTCCTCG-
TTAGATCAAACACA-39 (F12-DN214) and 59- GAACAAGCT-
TGCCATCATGGGAATGGGGATGTATTATCCTA-39 (F12-
DN416) containing a HindIII restriction site (underlined) and 59-
GAACGGATCCTTAAGCGTAATCAGGCACG-39 (F12-HA
R1) containing a BamHI restriction site (underlined) were used.
Figure 11. Conservation of the WD kinesin-1 binding site. (A)
Alignment of the WD kinesin-1 binding site in F12 orthologues in
chordopoxviruses with the consensus (L-E-W-E-E/D-S-I) sequence shown
below. (B) Alignment of the WD kinesin-binding site in other protein
reported to bind KLC with the consensus (L-E/D-W-D-D-S-A) sequence
shown below. Overall these sequences suggest the WD KBS conforms to
the sequence L-E/D-W/Q-D/E-D/E-S/N (Where Q is another aromatic
residue). The Human 14-3-3 protein and calsyntenin-1 and calsyntenin-2
contain two WD motifs shown as A and B in the alignment. Accession
numbers are VACVWR F12 (AAO89330), Lister F12 (DQ121394.1) Myxoma
virus (MYXV: NP_051735), Yaba-like disease virus (YLDV: NP_073411),
Swinepox virus (SWPV: NP_570184.1), Molluscum contagiosum virus
(MOCV: MC019L), Goatpox virus (GTPV: YP_001293217.1), Bovine papular
stomatitis virus (BPSV: NP_957919.1), Yaba monkey tumor virus (YMTV:
NP_938282.1), Orf virus (ORFV: AAR98105.1), Canarypox virus (CNPV:
NP_955159.1), Fowlpox virus (FPV: NP_039072.1), VACV WR A36
(YP_233041), Human collapsin response mediator protein-2 (HsCRMP-2,
Q16555), Human calsyntenin-1 (HsCal1: CLSTN1), Human calsyntenin-2
(HsCal2: CLSTN2), Human calsyntenin-3 (HsCal3: CLSTN3), Human 14-3-3
protein (Hs14-3-3: BAG35533), Human caytaxin (HsCaytaxin: NM_033064)
and Human amyloid precursor protein (HsAPP: 351 APP).
doi:10.1371/journal.ppat.1000785.g011
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The PCR product was digested with HindIII and BamHI and
ligated into HindIII and BamHI- restricted pSEL, a pBluescipt
vector containing the VACV synthetic early/late (E/L) [58] to
form the pSE/L-F12-DN truncated mutants. For the C-terminal
mutants, the oligonucleotides 59-GAACGGATCCTTAGGTAG-
TATTGTCATCATCGTGAT-39 (F12-DC128); 59-GAACGGA-
TCCTTAGATTTTCCATCCACAATTATTG-39 (F12-DC330)
and 59-GAACGGATCCTTAATACATCTGTTTCCTATAAT-
CGTT-39 (F12-DC476) containing a BamHI restriction site
(underlined) and 59-GAACAAGCTTATGTTAAACAGGGTA-
CAAATCTTG-39 (F12-F1) containing a HindIII restriction site
(underlined) were used. To generate A36-HA primers A36-F
HindIII BamHI, 59-CCCAAGCTTATGATGCTGGTACCTCT-
TATCACGG-39 and A36-R HA BamHI, 59- GGAGGATCCTT-
AAGCGTAATCTGGAACATCGTATGGGTACACCAATGA-
TACGACCGATGATTC-39 were used. The PCR fragments
were digested with HindIII and BamHI and ligated into HindIII-
and BamHI-digested pSEL to form the pSEL-F12-DC truncated
mutants. The WD motifs within A36 and F12 were mutated to
alanines (F12-HA WDD534AAA and A36-HA WDN95AAA)
using the QuikChange Site-Directed Mutagenesis Kit (Stratagene)
using pSEL-F12-HA and pSEL-A36-HA as template.
Infection and transfection for ectopic protein expression
HeLa cells were seeded on sterile glass coverslips and infected
with VACV. At 2 h p.i. cells were transfected with 1 mg of plasmid
using Fugene 6 (Roche Diagnostics) following the manufacturer’s
instructions. At 12 h post-transfection the cells were harvested or
fixed and processed for immunofluorescence as detailed below.
Antibodies and cytochemical reagents
Antibodies used were mouse mAb 63–90 a-KLC (IgG1) [73],
mouse mAb H2 a-KHC (IgG2b) [60], mouse mAb 6.3 a-A36
[72], rat mAb 19C2 a-B5 [13] directly conjugated to Alex546,
mouse mAb AB1.1 a-D8 [50], mouse mAb L2 a-KLC (Abcam),
mouse mAb HA.11 a-HA (Convance Research Products), rat high
Figure 12. The F12 WDmotif is needed for kinesin-1 recruitment and IEV transport. (A) HeLa cells were infected at 5 pfu/cell with vDF12L-
EGFPA5L for 2 h. Cells were then transfected with plasmids expressing WT or mutant F12-HA, and 10 h later were stained with mAbs against HA
(blue) or KHC (red), or visualized for EGFP. The overlay is shown in the Merge image. In cells transfected with F12-WT-HA the particles are widely
distributed and can recruit both F12-HA and KHC (white in merged image). In cells transfected with the mutant F12-AAA-HA the particles remain
centrally localized, and are unable to recruit either F12-HA or KHC. (B) Cells were infected and transfected as in (A) and then stained for HA (blue), and
phalloidin (red) to identify actin tails. Top panels shows F12-WT-HA is targeted to widely distributed particles and actin tails are formed at the plasma
membrane. Note virions on actin tails are negative for F12L-HA. Bottom panel show absence of F12 recruitment and lack of actin tail formation. Insets
show62.5 enlargements of the boxed regions. Scale bar = 10 mm.
doi:10.1371/journal.ppat.1000785.g012
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affinity a-HA mAb (Roche) and rabbit anti-HA (Sigma). Actin was
visualized with phalloidin labelled with Alexa Fluor 488 and 647
(Molecular Probes).
Triton X-114 extraction
Cells were partitioned using Triton X-114 as described
previously [50].
Statistical analysis
In each experiment the number of actin tails per cell were
counted for 10 cells for each infection/transfection, and the
experiment was performed three times. Data were analysed by the
Student’s t-test to test the significance of the results.
Microscopy
Cells were infected with VACV for 12 h, washed in ice-cold
phosphate buffered saline (PBS) and fixed in 4% paraformalde-
hyde (PFA) in 250 mM Hepes pH 7.4 for 10 min on ice, and then
in 4 or 8% PFA at room temperature (RT) for 10–50 min. Cells
were permeabilised in 0.1 TritonX-100 in PBS for 10 min at RT.
Alternatively, cells were for permeabilised for 5 min at RT in PBS
containing 0.1% saponin, and the detergent was retained in all
subsequent buffers when processing saponin-permeabilised cover-
slips. Fixed cells were processed for immunofluorescence as
described previously [18]. Confocal images were captured using
a Zeiss Pascal or Zeiss 510 Meta confocal microscopes using Zeiss
LSM software. Images were assembled using ImageJ (http://
rsbweb.nih.gov/ij/) and Adobe Photoshop (Adobe Systems).
Images shown are maximum projections of confocal Z stacks with
accompanying phase transmission image. For conventional
electron microscopy, at 12 h post infection cells were fixed in
0.5% glutaraldehyde-200 mM sodium cacodylate (pH 7.4) for
30 min, washed in 200 mM sodium cacodylate, and postfixed in
1% osmium tetroxide-1.5% potassium ferrocyanide for 60 min at
room temperature. The cells were washed in water, incubated in
0.5% magnesium-uranyl acetate overnight at 4uC, washed again
in water, dehydrated in ethanol, and embedded flat in Epon.
Sections were cut parallel to the surface of the dish. Serial sections
were collected onto slot grids, and lead citrate was added for
contrast. Grids were viewed on a FEI Tecnai G2 transmission
electron microscope. Images were acquired using a CCD camera.
For cryoimmuno-electron microscopy primary antibodies were
detected using antibodies for appropriate species then protein A-
gold 6 nm conjugate.
Bioinformatics
BLAST searches [74] were conducted at NCBI (http://www.
ncbi.nlm.nih.gov/blast). Sequence alignments were performed
using Clustal X [75] and Jalview [76] and analysed using
GeneDoc (http://www.psc.edu/biomed/genedoc). The predicted
TPR domains 6–12 of F12 were subjected to structural modelling
based on the alignment with KLC2 (Figure 1) and the structure of
KLC2 TPR region (pdb ID:3CEQ). The MODELLER software
[77] was used to create 30 potential models of this protein region
and these were analyzed using the PROCHECK [78], WHAT IF
[79] and Verify3D [80] algorithms to ensure the satisfaction of
stereochemical constraints. The model with the lowest energy and
fewest spatial violations was selected as the most accurate
representation of this domain. Protein structure illustrations were
generated with the PyMOL Molecular Graphics System (http://
www.pymol.org).
Supporting Information
Figure S1 Kyte-Doolittle hydropathy plots of the VACV WR
F12 and Homo sapiens KLC1 (HsKLC1). Note VACVWR F12 and
HsKLC are similar in length and exhibit a similar oscillating
hydrophobicity profile.
Found at: doi:10.1371/journal.ppat.1000785.s001 (0.83 MB PDF)
Figure S2 F12 is a cytosolic protein. F12-HA TritonX-114
partitioning. HeLa cells were infected at 5 pfu/cell with vF12L-
HA for 12 h. Cells were then collected, lysed and subjected to
TritonX-114 partitioning (Materials and Methods). Proteins in the
soluble aqueous (Aq) or membrane detergent (Det) fractions were
resolved by SDS-PAGE and immunoblotted with mAbs against
HA (F12-HA) (left panel), or VACV protein D8 (membrane
protein) and GSK3b (cytosolic protein) (right panel). The positions
of molecular size markers are indicated in kDa.
Found at: doi:10.1371/journal.ppat.1000785.s002 (0.47 MB
PDF)
Figure S3 Alignment of F12 orthologues. F12 orthologues from
different chordopoxvirus genera were aligned using Clustal-X and
are displayed using the Clustal colour scheme (http://www.
jalview.org/help/html/colourSchemes/clustal.html). The posi-
tions of TPRs numbered 1–14 are indicated above the alignment.
The F12 TPRs that were aligned with KLC TPRs in Figure 1 are
TPRs 6–10 and 12. Note the conservation of aromatic residues
throughout the alignment and the lack of N-terminal heptad
repeats, which mediate KHC binding by KLC. Abbreviations:
BPSV, Bovine papular stomatitis virus; CNPV, canarypox virus;
FWPV, fowlpox virus; GTPV, goatpox virus; MOCV, molluscum
contagiosum; MYXV, myxoma virus; ORFV, orf virus; SWPV,
Figure 13. The F12 WD motif is needed for kinesin-1
recruitment. Quantification of actin tail formation by analysis of data
shown in Figures 12 and S8. Data are the means +/2 SEM of triplicate
experiments. Note mutation of F12 WD motif inhibits actin tail
formation, whereas mutation of the A36 WD motif does not.
doi:10.1371/journal.ppat.1000785.g013
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swinepox virus; WR, VACV strain Western Reserve; YMTV,
yaba monkey tumor virus.
Found at: doi:10.1371/journal.ppat.1000785.s003 (4.95 MB TIF)
Figure S4 Full length F12 protein is required for IEV transport
to cell periphery. HeLa cells were infected at 5 pfu/cell with
vDF12L and at 2 h p.i. were transfected with plasmids expressing
full length F12L-HA or the indicated F12 mutants. The cells were
fixed at 12 h p.i., permeabilised and stained with mAb against HA
(blue), or B5 (red), and phalloidin-Alexa Fluor 488 to label
filamentous actin (green). Cells were then viewed by confocal
microscopy. The insert shows B5-positive virus particles at the tips
of actin tails in cells transfected with the WT F12. Scale
bar = 10 mm.
Found at: doi:10.1371/journal.ppat.1000785.s004 (4.38 MB PDF)
Figure S5 F12 co-localises with kinesin-1. Confocal microscopy
showing colocalisation of F12-HA and KHC. HeLa cells were
mock-infected or infected with vF12L-HA at 5 pfu/cell. At 12 h
p.i. cells were permeabilised and stained with a-HA (F12-HA,
green) and a-KHC (red). The right panels show the merged image.
Scale bar = 10 mm.
Found at: doi:10.1371/journal.ppat.1000785.s005 (3.44 MB PDF)
Figure S6 Mutant F12 and A36 proteins are stable in VACV
infected cells. HeLa cells were infected at 5 pfu/cell with vDF12L
or vDA36R for 2 h. Cells were then were transfected with plasmids
expressing HA tagged WT or mutant F12 or A36 proteins (F12-
WT-HA, F12-AAA-HA, A36-WT-HA, and A36-AAA-HA). 10 h
later the cells were lysed and lysates were analysed by SDS-PAGE
and immunblotting with anti-HA mAb. The positions of molecular
size markers are indicated in kDa.
Found at: doi:10.1371/journal.ppat.1000785.s006 (0.65 MB PDF)
Figure S7 Conservation of the WD KBS in A36 chordopox-
viruses orthologues. Alignment of the WD kinesin-1 binding site in
A36 chordopoxviruses orthologues with the consensus sequence
(L-N-W-D-N-+-+). Accession numbers are SWPV 123 (NP_
570283), MYXV m125R (NP_051839), EMV (AJ315003), GTPV
gp121 (YP_001293318), VACV WR A36 (YP_233041), YLDV
126R (NP_073511), DPV gp136 (YP_002302476).
Found at: doi:10.1371/journal.ppat.1000785.s007 (0.61 MB
PDF)
Figure S8 The A36 WD motif is not required for recruitment of
kinesin-1 to IEV or for virion transport to the cell surface. HeLa
cells were infected at 5 pfu/cell with vDA36R-EGFPA5L for 2 h.
Cells were then transfected with plasmids expressing A36-WT-HA
or A36-AAA-HA for 10 h. Cells were stained with mAbs against
HA (blue) and KHC (red), and EGFP were visualized directly.
Cells were viewed by confocal microscopy. The merged image is
shown on the right. The insets show 62.5 enlargements of the
boxed regions and illustrate that both A36-WT-HA and A36-
AAA-HA co-localise with KHC and virus particles. (B) Cells were
treated as in (A) and were counterstained with phalloidin to label
filamentous actin (red). Numerous actin tails are visible in cells
transfected with A36-WT-HA and A36-AAA-HA. Scale
bars = 10 mm.
Found at: doi:10.1371/journal.ppat.1000785.s008 (5.65 MB PDF)
Video S1 Tilt series electron microscopy showing vDF12L
arefully wrapped. Images were acquired from a 90-nm thin
section stained with Reynold’s lead citrate, 11 images at 10 degree
increments were captured +/2 50 degrees tilt angle. Images were
aligned with Adobe Photoshop CS4 and made into a movie using
GIF Movie Gear and further compressed with Windows Media
Encoder. Selected images are shown in Figure 10 (B,F,J,N), the
complete animated tilt series shows areas of the virion that appear
not to be wrapped with a double membrane are indeed fully
associated with enveloping membrane when perpendicular to the
electron beam.
Found at: doi:10.1371/journal.ppat.1000785.s009 (0.25 MB
WMV)
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